SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,814.54 |
| Enterprise Value ($M) | 2,381.54 |
| Book Value ($M) | 703.26 |
| Book Value / Share | 10.27 |
| Price / Book | 4.00 |
| NCAV ($M) | 524.86 |
| NCAV / Share | 7.67 |
| Price / NCAV | 5.36 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.34 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.32 |
| Current Ratio | 8.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 666.28 |
| Assets | 844.68 |
| Liabilities | 141.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Commodore Capital Lp | |||
| 13G/A | Flynn James E | 4.98 | 12.87 | |
| 13G/A | Samlyn Capital, Llc | 3.80 | -23.50 | |
| 13G | Rtw Investments, Lp | 6.10 | ||
| 13G | Fmr Llc | 9.99 | ||
| 13G/A | Incyte Corp | 1.50 | -74.83 | |
| 13G/A | Federated Hermes, Inc. | 3.98 | -36.83 | |
| 13G/A | Biotechnology Value Fund L P | 4.80 | -7.59 | |
| 13G/A | Wellington Management Group Llp | 3.48 | -45.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 83,503 | 435,469 | 19.18 | |
| 60,618 | 267,746 | 22.64 | |
| 103,823 | 352,130 | 29.48 | |
| 118,267 | 436,833 | 27.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNKD – MannKind Corporation | MNOV – MediciNova, Inc. |
| MRNS – Marinus Pharmaceuticals, Inc. | MURA – Mural Oncology plc |
| NAII – Natural Alternatives International, Inc. |
Financial data and stock pages provided by
Fintel.io